BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 120517
Published online Sep 19, 2026. doi: 10.5498/wjp.120517
Table 3 Neuroimaging findings, mean ± SD/n (%)
Imaging feature
PSD group (n = 68)
Non-PSD group (n = 88)
P value
Infarct volume (cm3)9.2 ± 3.15.1 ± 2.0< 0.001
Multiple infarcts28 (41.2)25 (28.4)0.089
White matter hyperintensities
    Fazekas periventricular2.1 ± 0.61.2 ± 0.5< 0.001
    Fazekas deep WM1.9 ± 0.51.0 ± 0.4< 0.001
    Fazekas total score4.0 ± 1.02.2 ± 0.8< 0.001
Brain atrophy
    GCA frontal1.8 ± 0.61.1 ± 0.5< 0.001
    GCA parietal1.3 ± 0.51.0 ± 0.40.065
    MTA score1.6 ± 0.71.0 ± 0.50.003
    Global atrophy (GCA total)1.5 ± 0.51.1 ± 0.40.012
    Microbleed count2.8 ± 1.91.5 ± 1.20.009
Perfusion parameters
    ADC (× 10-3 mm2/second)0.80 ± 0.110.90 ± 0.120.032
    TTP (seconds)122 ± 12108 ± 90.018
    CBF (mL/100 g/minutes)32.5 ± 6.838.2 ± 7.50.028


Write to the Help Desk